The U.S. Food and Drug Administration (FDA) has approved a fecal transplant therapy to prevent recurrence of a bacterial infection that kills up to 30,000 people a year. The therapy, Rebyota, is the first fecal transplant product approved in the United States, the FDA said in a statement. It’s cleared to combat Clostridioides difficile, or… Continue reading FDA Gives First-Ever Approval for Fecal Transplant Therapy